# Virtual Nodule Clinic

Type: Product

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/virtual-nodule-clinic
Canonical HTML page: https://gethealthbrief.com/entity/virtual-nodule-clinic

## Timeline

- **2026-02-27**: TGA Approval — Australian regulators approve the Virtual Nodule Clinic for clinical use.
- **2022-09-20**: Series A Funding — Company raises $14M to scale global commercial operations.
- **2021-03-15**: FDA Clearance — Optellum receives first-of-its-kind FDA clearance for lung cancer AI.

## Recent coverage (1 stories)

### Optellum Gains TGA Approval for AI Lung Cancer Diagnostic Tool in Australia
2026-02-27 02:29:49 · Sentiment: Positive · Impact: 7/10 · Sources: 3

Optellum has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for its AI-driven lung nodule management platform. This expansion allows Australian clinicians to utilize advanced imaging analytics to improve early lung cancer detection and streamline patient care pathways.
Full story: https://gethealthbrief.com/story/optellum-tga-approval-australia-lung-cancer-ai

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.